SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-23-098942
Filing Date
2023-12-27
Accepted
2023-12-27 17:03:10
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea190762-424b3_neurosense.htm 424B3 38615
2 GRAPHIC image_001.jpg GRAPHIC 4148
3 GRAPHIC image_002.jpg GRAPHIC 2708
  Complete submission text file 0001213900-23-098942.txt   49377
Mailing Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562
Business Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562 972-9-9531142
NeuroSense Therapeutics Ltd. (Filer) CIK: 0001875091 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-260338 | Film No.: 231518653
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)